The global viral vaccine market is currently undergoing a paradigm shift. Driven by technological advancements such as mRNA platforms, viral vectors, and recombinant proteins, the industry is no longer confined to traditional manufacturing. As a premier OEM/ODM viral vaccines factory, we recognize that the commercial demand for high-quality immunologics has reached an all-time high, not only for human health but also within the critical livestock and veterinary sectors.
The industrial status of vaccines is characterized by a push toward decentralized manufacturing. Global suppliers are now expected to provide end-to-end solutions—from active pharmaceutical ingredient (API) sourcing to final fill-and-finish processes. The market value is projected to grow exponentially, fueled by emerging infectious diseases and a heightened global awareness of preventive medicine.
Rapid development cycles and modular production facilities are becoming the new industry standard for response to viral mutations.
Integration of AI in antigen selection and robotic automation in filling lines to ensure zero-contamination environments.
Greater emphasis on the link between animal health and human pandemic prevention, driving demand for veterinary viral vaccines.
Today's procurement needs are shifting toward customization and scalability. Large-scale pharmaceutical distributors and government agencies are increasingly looking for partners who can offer flexible OEM services, allowing them to brand high-efficacy vaccines while maintaining stringent GMP compliance.
As a leading Chinese biotech hub, Hangzhou Jeci Biochem Technology Co., Ltd. offers unparalleled advantages in the viral vaccine supply chain. China’s infrastructure allows for the world's most efficient cost-to-quality ratio, supported by a robust chemical and biological raw material ecosystem.
Our drugs and intermediates are widely utilized across various high-tech sectors:
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
SJ medical
